Initial Hospital Orders for CHF Exacerbation
Upon hospital arrival, immediately initiate IV loop diuretics at a dose equal to or exceeding the patient's chronic oral daily dose (or 40-80 mg IV furosemide if diuretic-naïve), start continuous monitoring, and obtain diagnostic testing—all within 60 minutes of presentation. 1
Immediate Monitoring and Stabilization (Within Minutes)
Establish continuous monitoring immediately upon arrival: 2
- Continuous pulse oximetry, blood pressure, respiratory rate, and ECG 2
- Oxygen therapy if SpO₂ <90% (otherwise use clinical judgment) 2
- Non-invasive ventilation (BiPAP/CPAP) for patients with respiratory distress 2
Assess cardiopulmonary stability as the critical first step: 2
- Respiratory rate, work of breathing, ability to lie flat, degree of hypoxia 2
- Signs of hypoperfusion: cool extremities, narrow pulse pressure, altered mental status, decreased urine output 2, 1
- Systolic and diastolic blood pressure, heart rate and rhythm 2
Diagnostic Testing (Concurrent with Treatment Initiation)
Order immediately upon arrival: 2, 1
- 12-lead ECG to exclude ST-elevation MI and assess for arrhythmias 2, 1
- Cardiac troponin to identify acute coronary syndrome 1
- Chest X-ray to assess pulmonary congestion (though may be normal in up to 20% of cases) 2, 1
- BNP or NT-proBNP if the contribution of heart failure to dyspnea is uncertain 1
- Complete metabolic panel, complete blood count, renal function (BUN/creatinine), electrolytes 2, 1
Echocardiography should be performed during hospitalization to assess ejection fraction, chamber size, wall thickness, and valve function, but is not needed immediately unless hemodynamic instability is present 2, 1
Bedside thoracic ultrasound for B-lines (lung rockets) indicating pulmonary edema and abdominal ultrasound for IVC diameter if expertise is available 2
Pharmacologic Management (Blood Pressure-Guided Algorithm)
For SBP >110 mmHg (Most Common Presentation):
Start IV loop diuretics within 60 minutes: 2, 1
- If already on loop diuretics: IV dose equal to or exceeding chronic oral daily dose 1
- If diuretic-naïve: furosemide 40-80 mg IV bolus 2
Consider IV vasodilators for severe fluid overload without hypotension: 1
- IV nitroglycerin starting at 5-10 mcg/min, titrate by 5-10 mcg/min every 3-5 minutes (using non-absorbing tubing) 3
- Target: symptom relief and blood pressure reduction while maintaining SBP >90-100 mmHg 3
For SBP <110 mmHg:
Diuretics remain first-line therapy 2
- Use lower initial doses and monitor closely for hypotension 2
- Avoid vasodilators 2
- Consider inotropic support (dobutamine 2-20 mcg/kg/min) if signs of hypoperfusion persist 4
Inadequate Diuretic Response:
Add a second diuretic such as a thiazide (metolazone) or increase aldosterone antagonist dose 1
Guideline-Directed Medical Therapy (GDMT) Management
Continue existing GDMT in patients with reduced ejection fraction unless contraindications or hemodynamic instability present 1
- ACE inhibitors/ARBs/ARNIs: continue if already on therapy 1
- Beta-blockers: continue if already on therapy and patient is stable 1
Do NOT start beta-blockers on day 1 if patient required oxygen and is acutely decompensated 1
Initiate GDMT during hospitalization once clinical stability achieved: 1
- Start SGLT2 inhibitors and mineralocorticoid receptor antagonists (MRAs) first (often day 1) as they have minimal blood pressure effects 1
- Delay ACE inhibitors/ARBs/ARNIs until volume optimized, no marked azotemia/hyperkalemia, and SBP >90-100 mmHg 1
- Start beta-blockers only after volume optimization, IV diuretics/vasodilators/inotropes discontinued, and clinical stability confirmed 1
Daily Monitoring Orders
Assess daily: 1
- Strict intake and output measurement 1
- Daily weights 1
- Vital signs including orthostatic blood pressures 1
- Clinical signs of perfusion (mental status, extremity temperature, urine output) and congestion (JVP, rales, edema) 1
- Electrolytes and renal function 1
Identify and Treat Precipitating Factors
Search for triggers: 1
- Acute coronary syndrome (troponin, ECG) 1
- Severe hypertension 1
- Arrhythmias (atrial fibrillation, ventricular tachycardia) 1
- Infections 1
- Pulmonary embolism 1
- Renal failure 1
- Medication/dietary noncompliance 1
Critical Pitfalls to Avoid
Do not delay diuretic therapy beyond 60 minutes of presentation—the "time-to-treatment" concept is critical in acute heart failure 2, 1
Do not discontinue GDMT for mild renal function decrease or asymptomatic blood pressure reduction unless truly contraindicated 1
Do not start beta-blockers in acutely decompensated patients requiring oxygen or IV therapies—wait until volume optimized and IV medications discontinued 1
Recognize that most CHF exacerbations present with normal or elevated blood pressure (63-77% have SBP >140 mmHg), not hypotension 2